Gestational trophoblastic diseases in the Philippines / (Record no. 2801)

000 -LEADER
fixed length control field 02613nam a22001577a 4500
003 - CONTROL NUMBER IDENTIFIER
control field DOH
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20210211110959.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 210211b ||||| |||| 00| 0 eng d
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Cagayan, Ma Stephanie Fay S.
245 00 - TITLE STATEMENT
Title Gestational trophoblastic diseases in the Philippines /
Statement of responsibility, etc. Ma Stephanie Fay S. Cagayan
520 3# - SUMMARY, ETC.
Summary, etc. Objectives: To describe the Philippine hospital-based prevalence rate of gestational trophoblastic disease (GTD) and to discuss changes in the management of GTD over the past decades. Study Design: A retrospective descriptive study was done with the following as sources of data: published report on the national incidence of GTD from 1977-1984 and its management, the Philippine Obstetrical and Gynecological Society (POGS)- Committee on Nationwide Statistics Reports 1985-1994, the 1997-2001 POGS Annual Reports on Diseases and Procedures, the 1997-2001 POGS Trophoblastic Disease Registry, the 1991-2001 University of the Philippines-Philippine General Hospital (UP-PGH) Trophoblastic Disease Registry and Annual Reports and the 1991-2001 UP-PGH Dept. of Obstetrics and Gynecology Annual Reports on Diseases and Procedures. Results: The prevalence rate of hydatidiform mole dropped from 7/1000 pregnancies in the early 80's to 2.7/1000 pregnancies from 1985-1994 with note of increase to 3.5/1000 in 1997-2001. At the UP-PGH the prevalence rate of hydatidiform mole is 13.96. This is because the hospital is a known tertiary referral center for GTDs. The national prevalence rate of choriocarcinomas and other trophoblastic neoplasias (GTN) has remained almost constant at 0.55 and 0.52 per 1000 pregnancies respectively from 1990-1994 and 1997-2001. Again, PGH showed a high prevalence for choriocarcinoma and other GTN at 8/1000 pregnancies. Because patients with GTD are invariably indigent, modifications on standard treatment practices have been adapted to bring down the cost of chemotherapy without sacrificing survival and remission rates such as outpatient treatment with methotrexate as chemoprophylaxis and treatment for low risk GTN and use of modified EMA-CO for high risk GTN. Surgery has been widely used as an adjunct to treatment. Conclusion: Despite advances in diagnosis and management of GTD, GTD remains a disease to reckon with in the country. Reasons for poor outcome such as poor patient compliance, inadequate/poor quality of reporting and inadequate resources in some areas should further be examined.
580 ## - LINKING ENTRY COMPLEXITY NOTE
Linking entry complexity note In: Acta Medica Philippina, 2006 vol. 40 (1) pages: 7-12
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Gestational Trophoblastic Disease
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Journal Article
999 ## -
-- 2801
-- 2801
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Home library Current library Shelving location Date acquired Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
    National Library of Medicine     DOH Central Library DOH Central Library Electronic Resource Section 02/11/2021   J000017 D0001J000017 02/11/2021 02/11/2021 Journal Article